E2F2 and neoplasm: Disruption of LINC01232/E2F2/NBR1/MHC‐I by shRNA or blocking the corresponding antibodies largely diminished the tumor‐supportive effects of LINC01232 and suppressed tumor growth driven by M2‐type macrophages.